Ashford Capital Management’s Merck MRK Stock Holding History

Ashford Capital Management’s Portfolio MRK Stock Details MRK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$1.57M	Sell	13,034 -13,949	-52%	-$1.61M	0.19%	71
2025 Q4	$2.84M	Buy	26,983 +300	+1%	+$28.2K	0.32%	61
2025 Q3	$2.24M	Buy	26,683 +8,321	+45%	+$685K	0.25%	65
2025 Q2	$1.45M	Sell	18,362 -2,705	-13%	-$215K	0.17%	70
2025 Q1	$1.89M	Buy	21,067 +3,722	+21%	+$348K	0.24%	56
2024 Q4	$1.73M	Sell	17,345 -27,364	-61%	-$2.82M	0.2%	60
2024 Q3	$5.08M	Sell	44,709 -11,809	-21%	-$1.4M	0.63%	42
2024 Q2	$7M	Buy	56,518 +3,303	+6%	+$425K	0.94%	35
2024 Q1	$7.02M	Buy	53,215 +4,950	+10%	+$610K	0.95%	34
2023 Q4	$5.26M	Sell	48,265 -9,100	-16%	-$945K	0.7%	37
2023 Q3	$5.91M	Sell	57,365 -810	-1%	-$87.3K	0.87%	34
2023 Q2	$6.71M	Sell	58,175 -328	-0.6%	-$37.2K	0.94%	30
2023 Q1	$6.22M	Buy	58,503 +12,984	+29%	+$1.4M	0.93%	31
2022 Q4	$5.05M	Buy	45,519 +86	+0.2%	+$8.79K	0.78%	35
2022 Q3	$3.91M	Sell	45,433 -18,624	-29%	-$1.66M	0.6%	36
2022 Q2	$5.84M	Buy	64,057 +474	+0.7%	+$42K	0.83%	35
2022 Q1	$5.22M	Buy	63,583 +9,883	+18%	+$779K	0.56%	43
2021 Q4	$4.12M	Buy	53,700 +48,900	+1,019%	+$3.89M	0.41%	47
2021 Q3	$361K	Hold	4,800	–	–	0.03%	99
2021 Q2	$373K	Sell	4,800 -230	-5%	-$17.1K	0.03%	97
2021 Q1	$370K	Hold	5,030	–	–	0.03%	92
2020 Q4	$393K	Buy	5,030 +314	+7%	+$24K	0.04%	93
2020 Q3	$373K	Sell	4,716 -210	-4%	-$16.4K	0.04%	84
2020 Q2	$363K	Sell	4,926 -628	-11%	-$47.3K	0.05%	80
2020 Q1	$408K	Hold	5,554	–	–	0.07%	77
2019 Q4	$482K	Hold	5,554	–	–	0.06%	75
2019 Q3	$446K	Hold	5,554	–	–	0.06%	79
2019 Q2	$444K	Hold	5,554	–	–	0.06%	81
2019 Q1	$441K	Hold	5,554	–	–	0.06%	81
2018 Q4	$405K	Hold	5,554	–	–	0.07%	97
2018 Q3	$376K	Sell	5,554 -210	-4%	-$13.4K	0.05%	99
2018 Q2	$334K	Buy	5,764 +1,782	+45%	+$101K	0.04%	99
2018 Q1	$207K	Hold	3,982	–	–	0.03%	99
2017 Q4	$214K	Sell	3,982 -1,153	-22%	-$63.9K	0.03%	99
2017 Q3	$314K	Hold	5,135	–	–	0.05%	95
2017 Q2	$314K	Sell	5,135 -524	-9%	-$31.9K	0.05%	92
2017 Q1	$343K	Hold	5,659	–	–	0.07%	94
2016 Q4	$318K	Buy	5,659 +209	+4%	+$12.2K	0.06%	94
2016 Q3	$325K	Hold	5,450	–	–	0.07%	96
2016 Q2	$300K	Buy	+5,450	New	+$290K	0.07%	97

Other funds holding MRK

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Ashford Capital Management's MRK Position: Q1 2026 in Review

Ashford Capital Management reduced its Merck (MRK) stake by 52% in Q1 2026, selling an estimated $1.61M and leaving 13,034 shares worth $1.57M. The position accounts for 0.19% of the portfolio, ranked #71.

Ashford Capital Management first reported a position in MRK in Q2 2016 and has held it in 40 quarters since. The position peaked at $7.02M in Q1 2024. 3,780 funds tracked by Wall St. Rank hold MRK as of Q1 2026.

Ashford Capital Management held 13,034 shares of Merck worth $1.57M as of Q1 2026.
Ashford Capital Management sold 13,949 Merck shares in Q1 2026, an estimated $1.61M.
Merck made up 0.19% of Ashford Capital Management's portfolio in Q1 2026, its #71 holding.
Ashford Capital Management first reported a position in Merck in Q2 2016 and has held it in 40 quarters since.
Ashford Capital Management's Merck position peaked at $7.02M in Q1 2024.
3,780 funds tracked by Wall St. Rank held Merck as of Q1 2026.

Based on Ashford Capital Management's 13F filing for Q1 2026, filed 15 May 2026.